Table of Content

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights


2. Assumptions and Research Methodology


3. Executive Summary: Global Stroke Treatment Market


4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Stroke Treatment Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)


5. Market Outlook

5.1. Key Industry Developments

5.2. Pipeline Analysis

5.3. Epidemiology Analysis


6. Global Stroke Treatment Market Value and Forecast, by Type

6.1. Introduction & Definition

6.2. Global Stroke Treatment Market Value Forecast, by Type, 2017–2027

6.2.1. Ischemic Stroke

6.2.2. Hemorrhagic Stroke

6.3. Global Stroke Treatment Market Attractiveness, by Type


7. Global Stroke Treatment Market Value and Forecast, by Drug Class

7.1. Introduction & Definition

7.2. Global Stroke Treatment Market Value Forecast, by Drug Class, 2017–2027

7.2.1. Tissue Plasminogen Activator (tPA)

7.2.2. Anticoagulants

7.2.3. Antiplatelets

7.2.4. Anticonvulsants

7.2.5. Others

7.3. Global Stroke Treatment Market Attractiveness, by Drug Class


8. Global Stroke Treatment Market Value and Forecast, by Distribution Channel

8.1. Introduction

8.2. Global Stroke Treatment Market Value Forecast, by Distribution Channel, 2017–2027

8.2.1. Hospital Pharmacies

8.2.2. Retail Pharmacies

8.2.3. Online Pharmacies

8.3. Global Stroke Treatment Market Attractiveness, by Distribution Channel


9. Global Stroke Treatment Market Value and Forecast, by Region

9.1. Introduction

9.2. Stroke Treatment Market Value Forecast, by Region, 2017–2027

9.2.1. North America

9.2.2. Europe

9.2.3. Asia Pacific

9.2.4. Latin America

9.2.5. Middle East & Africa

9.3. Global Stroke treatment Market Attractiveness, by Region


10. North America Stroke Treatment Market Analysis and Forecast

10.1. Introduction

10.2. North America Stroke Treatment Market Value Forecast, by Type, 2017–2027

10.2.1. Ischemic Stroke

10.2.2. Hemorrhagic Stroke

10.3. North America Stroke Treatment Market Value Forecast, by Drug Class, 2017–2027

10.3.1. Tissue Plasminogen Activator (tPA)

10.3.2. Anticoagulants

10.3.3. Antiplatelets

10.3.4. Anticonvulsants

10.3.5. Others

10.4. North America Stroke Treatment Market Value Forecast, by Distribution Channel, 2017–2027

10.4.1. Hospital Pharmacies

10.4.2. Retail Pharmacies

10.4.3. Online Pharmacies

10.5. North America Stroke Treatment Market Value Forecast, by Country/Sub-region, 2017–2027

10.5.1. U.S.

10.5.2. Canada

10.6. North America Stroke treatment Market Attractiveness Analysis

10.6.1. By Type

10.6.2. By Drug Class

10.6.3. By Distribution Channel

10.6.4. By Country


11. Europe Stroke Treatment Market Analysis and Forecast

11.1. Introduction

11.2. Europe Stroke Treatment Market Value Forecast, by Type, 2017–2027

11.2.1. Ischemic Stroke

11.2.2. Hemorrhagic Stroke

11.3. Europe Stroke Treatment Market Value Forecast, by Drug Class, 2017–2027

11.3.1. Tissue Plasminogen Activator (tPA)

11.3.2. Anticoagulants

11.3.3. Antiplatelets

11.3.4. Anticonvulsants

11.3.5. Others

11.4. Europe Stroke Treatment Market Value Forecast, by Distribution Channel, 2017–2027

11.4.1. Hospital Pharmacies

11.4.2. Retail Pharmacies

11.4.3. Online Pharmacies

11.5. Europe Stroke Treatment Market Value Forecast, by Country/Sub-region, 2017–2027

11.5.1. Germany

11.5.2. U.K.

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Rest of Europe

11.6. Europe Stroke treatment Market Attractiveness Analysis

11.6.1. By Type

11.6.2. By Drug Class

11.6.3. By Distribution Channel

11.6.4. By Country/Sub-region


12. Asia Pacific Stroke Treatment Market Analysis and Forecast

12.1. Introduction

12.2. Asia Pacific Stroke Treatment Market Value Forecast, by Type, 2017–2027

12.2.1. Ischemic Stroke

12.2.2. Hemorrhagic Stroke

12.3. Asia Pacific Stroke Treatment Market Value Forecast, by Drug Class, 2017–2027

12.3.1. Tissue Plasminogen Activator (tPA)

12.3.2. Anticoagulants

12.3.3. Antiplatelets

12.3.4. Anticonvulsants

12.3.5. Others

12.4. Asia Pacific Stroke Treatment Market Value Forecast, by Distribution Channel, 2017–2027

12.4.1. Hospital Pharmacies

12.4.2. Retail Pharmacies

12.4.3. Online Pharmacies

12.5. Asia Pacific Stroke Treatment Market Value Forecast, by Country/Sub-region, 2017–2027

12.5.1. Japan

12.5.2. China

12.5.3. India

12.5.4. Australia & New Zealand

12.5.5. Rest of Asia Pacific

12.6. Asia Pacific Stroke treatment Market Attractiveness Analysis

12.6.1. By Type

12.6.2. By Drug Class

12.6.3. By Distribution Channel

12.6.4. By Country/Sub-region

13. Latin America Stroke Treatment Market Analysis and Forecast

13.1. Introduction

13.2. Latin America Stroke Treatment Market Value Forecast, by Type, 2017–2027

13.2.1. Ischemic Stroke

13.2.2. Hemorrhagic Stroke

13.3. Latin America Stroke Treatment Market Value Forecast, by Drug Class, 2017–2027

13.3.1. Tissue Plasminogen Activator (tPA)

13.3.2. Anticoagulants

13.3.3. Antiplatelets

13.3.4. Anticonvulsants

13.3.5. Others

13.4. Latin America Stroke Treatment Market Value Forecast, by Distribution Channel, 2017–2027

13.4.1. Hospital Pharmacies

13.4.2. Retail Pharmacies

13.4.3. Online Pharmacies

13.5. Latin America Stroke Treatment Market Value Forecast, by Country/Sub-region, 2017–2027

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Latin America Stroke treatment Market Attractiveness Analysis

13.6.1. By Type

13.6.2. By Drug Class

13.6.3. By Distribution Channel

13.6.4. By Country/Sub-region

14. Middle East & Africa Stroke treatment Market Analysis and Forecast

14.1. Introduction

14.2. Middle East & Africa Stroke Treatment Market Value Forecast, by Type, 2017–2027

14.2.1. Ischemic Stroke

14.2.2. Hemorrhagic Stroke

14.3. Middle East & Africa Stroke Treatment Market Value Forecast, by Drug Class, 2017–2027

14.3.1. Tissue Plasminogen Activator (tPA)

14.3.2. Anticoagulants

14.3.3. Antiplatelets

14.3.4. Anticonvulsants

14.3.5. Others

14.4. Middle East & Africa Stroke Treatment Market Value Forecast, by Distribution Channel, 2017–2027

14.4.1. Hospital Pharmacies

14.4.2. Retail Pharmacies

14.4.3. Online Pharmacies

14.5. Middle East & Africa Stroke Treatment Market Value Forecast, by Country/Sub-region, 2017–2027

14.5.1. GCC Countries

14.5.2. South Africa

14.5.3. Rest of Middle East & Africa

14.6. Middle East & Africa Stroke treatment Market Attractiveness Analysis

14.6.1. By Type

14.6.2. By Drug Class

14.6.3. By Distribution Channel

14.6.4. By Country/Sub-region

15. Competition Landscape

15.1. Global Stroke Treatment Market Position Analysis, by Company, 2018

15.2. Company Profiles

15.2.1. Bristol-Myers Squibb Company

15.2.1.1. Company Description

15.2.1.2. Business Overview

15.2.1.3. Financial Overview

15.2.1.4. Strategic Overview

15.2.1.5. SWOT Analysis

15.2.2. Boehringer Ingelheim GmbH

15.2.2.1. Company Description

15.2.2.2. Business Overview

15.2.2.3. Financial Overview

15.2.2.4. Strategic Overview

15.2.2.5. SWOT Analysis

15.2.3. Daiichi Sankyo Company, Limited

15.2.3.1. Company Description

15.2.3.2. Business Overview

15.2.3.3. Financial Overview

15.2.3.4. Strategic Overview

15.2.3.5. SWOT Analysis

15.2.4. F. Hoffmann-La Roche Ltd

15.2.4.1. Company Description

15.2.4.2. Business Overview

15.2.4.3. Financial Overview

15.2.4.4. Strategic Overview

15.2.4.5. SWOT Analysis

15.2.5. Johnson & Johnson Services, Inc.

15.2.5.1. Company Description

15.2.5.2. Business Overview

15.2.5.3. Financial Overview

15.2.5.4. Strategic Overview

15.2.5.5. SWOT Analysis

15.2.6. Sanofi

15.2.6.1. Company Description

15.2.6.2. Business Overview

15.2.6.3. Financial Overview

15.2.6.4. Strategic Overview

15.2.6.5. SWOT Analysis

15.2.7. Amgen, Inc.

15.2.7.1. Company Description

15.2.7.2. Business Overview

15.2.7.3. Financial Overview

15.2.7.4. Strategic Overview

15.2.7.5. SWOT Analysis

15.2.8. Biogen Inc.

15.2.8.1. Company Description

15.2.8.2. Business Overview

15.2.8.3. Financial Overview

15.2.8.4. Strategic Overview

15.2.8.5. SWOT Analysis

15.2.9. AstraZeneca

15.2.9.1. Company Description

15.2.9.2. Business Overview

15.2.9.3. Financial Overview

15.2.9.4. Strategic Overview

15.2.9.5. SWOT Analysis



List of Figures



Figure 01: Global Stroke Treatment Market Value (US$ Mn) and Distribution (%), by Region, 2019 and 2027

Figure 02: Global Stroke Treatment Market Value (US$ Mn) Forecast, 2017–2027

Figure 03: Global Stroke Treatment Market Value Share (%), by Type, 2018

Figure 04: Global Stroke Treatment Market Value Share (%), by Drug Class, 2018

Figure 05: Global Stroke Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 06: Global Stroke Treatment Market Value Share (%), by Region, 2018

Figure 07: Stroke Treatment Market - Agreements, Collaborations, Partnerships & New Product Launch

Figure 08: Epidemiology of Stroke

Figure 09: Global Stroke Treatment Market Value Share (%), by Type, 2018 and 2027

Figure 10: Global Stroke Treatment Market Attractiveness, by Type, 2019–2027

Figure 11: Global Stroke Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ischemic Stroke, 2017–2027

Figure 12: Global Stroke Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hemorrhagic Stroke, 2017–2027

Figure 13: Global Stroke Treatment Market Value Share (%), by Drug Class, 2018 and 2027

Figure 14: Global Stroke Treatment Market Attractiveness, by Drug Class, 2019–2027

Figure 15: Global Stroke Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Tissue Plasminogen Activator (tPA), 2017–2027

Figure 16: Global Stroke Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Anticoagulants, 2017–2027

Figure 17: Global Stroke Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Antiplatelets, 2017–2027

Figure 18: Global Stroke Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Anticonvulsants, 2017–2027

Figure 19: Global Stroke Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 20: Global Stroke Treatment Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 21: Global Stroke Treatment Market Attractiveness, by Distribution Channel, 2019–2027

Figure 22: Global Stroke Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2017–2027

Figure 23: Global Stroke Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2017–2027

Figure 24: Global Stroke Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2017–2027

Figure 25: Global Stroke Treatment Market Value Share Analysis, by Region, 2018 and 2027

Figure 26: Global Stroke Treatment Market Attractiveness Analysis, by Region, 2019–2027

Figure 27: North America Stroke Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 28: North America Stroke Treatment Market Value Share Analysis, by Country, 2018 and 2027

Figure 29: North America Stroke Treatment Market Attractiveness Analysis, by Country, 2019–2027

Figure 30: North America Stroke Treatment Market Value Share (%), by Type, 2018 and 2027

Figure 31: North America Stroke Treatment Market Attractiveness, by Type, 2019–2027

Figure 32: North America Stroke Treatment Market Value Share (%), by Drug Class, 2018 and 2027

Figure 33: North America Stroke Treatment Market Attractiveness, by Drug Class, 2019–2027

Figure 34: North America Stroke Treatment Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 35: North America Stroke Treatment Market Attractiveness, by Distribution Channel, 2019–2027

Figure 36: Europe Stroke Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 37: Europe Stroke Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 38: Europe Stroke Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 39: Europe Stroke Treatment Market Value Share (%), by Type, 2018 and 2027

Figure 40: Europe Stroke Treatment Market Attractiveness, by Type, 2019–2027

Figure 41: Europe Stroke Treatment Market Value Share (%), by Drug Class, 2018 and 2027

Figure 42: Europe Stroke Treatment Market Attractiveness, by Drug Class, 2019–2027

Figure 43: Europe Stroke Treatment Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 44: Europe Stroke Treatment Market Attractiveness, by Distribution Channel, 2019–2027

Figure 45: Asia Pacific Stroke Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 46: Asia Pacific Stroke Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 47: Asia Pacific Stroke Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 48: Asia Pacific Stroke Treatment Market Value Share (%), by Type, 2018 and 2027

Figure 49: Asia Pacific Stroke Treatment Market Attractiveness, by Type, 2019–2027

Figure 50: Asia Pacific Stroke Treatment Market Value Share (%), by Drug Class, 2018 and 2027

Figure 51: Asia Pacific Stroke Treatment Market Attractiveness, by Drug Class, 2019–2027

Figure 52: Asia Pacific Stroke Treatment Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 53: Asia Pacific Stroke Treatment Market Attractiveness, by Distribution Channel, 2019–2027

Figure 54: Latin America Stroke Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 55: Latin America Stroke Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 56: Latin America Stroke Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 57: Latin America Stroke Treatment Market Value Share (%), by Type, 2018 and 2027

Figure 58: Latin America Stroke Treatment Market Attractiveness, by Type, 2019–2027

Figure 59: Latin America Stroke Treatment Market Value Share (%), by Drug Class, 2018 and 2027

Figure 60: Latin America Stroke Treatment Market Attractiveness, by Drug Class, 2019–2027

Figure 61: Latin America Stroke Treatment Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 62: Latin America Stroke Treatment Market Attractiveness, by Distribution Channel, 2019–2027

Figure 63: Middle East & Africa Stroke Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 64: Middle East & Africa Stroke Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 65: Middle East & Africa Stroke Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 66: Middle East & Africa Stroke Treatment Market Value Share (%), by Type, 2018 and 2027

Figure 67: Middle East & Africa Stroke Treatment Market Attractiveness, by Type, 2019–2027

Figure 68: Middle East & Africa Stroke Treatment Market Value Share (%), by Drug Class, 2018 and 2027

Figure 69: Middle East & Africa Stroke Treatment Market Attractiveness, by Drug Class 2019–2027

Figure 70: Middle East & Africa Stroke Treatment Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 71: Middle East & Africa Stroke Treatment Market Attractiveness, by Distribution Channel, 2019–2027

Figure 72: Global Stroke Treatment Market Position Analysis, by Top Company Ranking, 2018


List of Tables



Table 01: Pipeline Analysis for Stroke Treatment

Table 02: Global Stroke Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 03: Global Stroke Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 04: Global Stroke Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 05: Global Stroke Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 06: North America Stroke Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 07: North America Stroke Treatment Market Value (US$ Mn) Forecast, by Type, 2017?2027

Table 08: North America Stroke Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 09: North America Stroke Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017?2027

Table 10: Europe Stroke Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 11: Europe Stroke Treatment Market Value (US$ Mn) Forecast, by Type, 2017?2027

Table 12: Europe Stroke Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 13: Europe Stroke Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017?2027

Table 14: Asia Pacific Stroke Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 15: Asia Pacific Stroke Treatment Market Value (US$ Mn) Forecast, by Type, 2017?2027

Table 16: Asia Pacific Stroke Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 17: Asia Pacific Stroke Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017?2027

Table 18: Latin America Stroke Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 19: Latin America Stroke Treatment Market Value (US$ Mn) Forecast, by Type, 2017?2027

Table 20: Latin America Stroke Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 21: Latin America Stroke Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017?2027

Table 22: Middle East & Africa Stroke Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 23: Middle East & Africa Stroke Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017?2027

Table 24: Middle East & Africa Stroke Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 25: Middle East & Africa Stroke Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017?2027